Effect of Infliximab Therapy in Functional Improvement in Patients with Ankylosing Spondylitis
Ambar Konar, Debayan Ghorai, Aniketa Banerjee
Citation Information :
Konar A, Ghorai D, Banerjee A. Effect of Infliximab Therapy in Functional Improvement in Patients with Ankylosing Spondylitis. Indian J Phy Med Rehab 2017; 28 (2):59-63.
Ankylosing spondylitis. In: Firestein GS, editor. Kelley's textbook of rheumatology. 9th ed. Philadelphia (PA): Saunders; 2012.
A five-year cumulative analysis of labor-status and lost working days in patients with ankylosing spondylitis (AS). Arthritis Rheum 1998 Sep;41(9):S222.
The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatol 1997 Jul;36(7):766-771.
; Skosey, JL. Ankylosing spondylitis and related spondyloarthropathies. In Samter M, editor. Immunological diseases. Boston (MA): Little, Brown; 1989. p. 1509-1538.
Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial. Ann Rheum Dis 2006 Sep;65(9):1147-1153.
Sulfasalazine in the treatment of spondyloarthropathy. Arthritis Rheum 1995 May;38(5):618-627.
Methotrexate in severe ankylosing spondylitis: a randomised placebo controlled, double-blind observer study. Rheumatology 2001;40(Suppl 1):43.
Efficacy of methotrexate in ankylosing spondylitis: a randomized, double-blind, placebo-controlled trial. J Rheumatol 2004 Aug;31(8):1568-1574.
Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized placebo-controlled trial (ASSERT). Arthritis Rheum 2005 Feb;52(2):582-591.
Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2006 Jul;54(7):2136-2146.
Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab. Arthritis Res Ther 2005 Feb;7(3):R439-R444.
Evaluation of a functional index and an articular index in ankylosing spondylitis. J Rheumatol 1988 Feb;15(2):302-307.
Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab. Arthritis Rheum 2000 Jun;43(6):1346-1352.
Clinical and imaging correlates of response to treatment with infliximab in patients with ankylosing spondylitis. J Rheumatol 2001 Jul;28(7):1605-1614.
Infliximab improves productivity and reduces workday loss in patients with ankylosing spondylitis: results from a randomized, placebo-controlled trial. Arthritis Rheum 2006 Aug;55(4):569-574.
